Gs-9411    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
299嚢胞性線維症4

299. 嚢胞性線維症 [臨床試験数:1,592,薬物数:1,539(DrugBank:255),標的遺伝子数:81,標的パスウェイ数:162
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
4 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01025713
(ClinicalTrials.gov)
December 20091/12/2009A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)A Phase 1, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)Cystic Fibrosis;Mucociliary ClearanceDrug: GS-9411;Drug: PlaceboGilead SciencesNULLWithdrawn18 Years65 YearsBoth0Phase 1Australia
2NCT00999531
(ClinicalTrials.gov)
October 200920/10/2009A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy VolunteersA Phase 1, Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy VolunteersCystic Fibrosis;Mucociliary Clearance;Airway HydrationDrug: GS-9411;Drug: PlaceboGilead SciencesNULLCompleted18 Years65 YearsBoth24Phase 1Australia
3NCT00951522
(ClinicalTrials.gov)
September 20093/8/2009A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male VolunteersA Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCystic Fibrosis;Mucociliary Clearance;Airway HydrationDrug: GS-9411;Drug: PlaceboGilead SciencesNULLCompleted18 Years45 YearsMale15Phase 1Australia
4NCT00800579
(ClinicalTrials.gov)
November 200821/11/2008Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male VolunteersA Randomised, Double-blind, Placebo-controlled Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCystic FibrosisDrug: GS-9411;Drug: PlaceboGilead SciencesNULLCompleted18 Years45 YearsMale12Phase 1Australia